Nationwide seroprevalence of SARS-CoV-2 during the COVID-19 pandemic and prepandemic periods in Lao PDR
There was no evidence of cross-reactive neutralizing antibodies prior to the COVID-19 pandemic and the seroprevalence of SARS-CoV-2 was confirmed to be low in Lao PDR before the introduction of COVID-19 vaccines and the surge in infections from May 2021.
Authors
- Ooyanong Phonemixay
- Audrey Dubot‐Pérès (ORCID: https://orcid.org/0000-0003-1267-0725)
- Chirapha Keokhamphoui
- Manivanh Vongsouvath (ORCID: https://orcid.org/0000-0002-2249-7367)
- Anisone Chanthongthip
- Koukeo Phommasone (ORCID: https://orcid.org/0000-0002-3814-0522)
- Xavier Nicolas de Lamballerie (ORCID: https://orcid.org/0000-0001-7895-2720)
- Elizabeth A. Ashley (ORCID: https://orcid.org/0000-0002-7620-4822)
- Stéphane Priet (ORCID: https://orcid.org/0000-0001-7102-3654)
- Chanthala Souksakhone
- Karine Barthélémy (ORCID: https://orcid.org/0000-0001-6343-2175)
Institutions
- Inserm (FR)
- Aix-Marseille Université (FR)
- Mahosot Hospital (LA)
- University of Oxford (GB)
- National Blood Transfusion Service (NG)
- Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit (LA)
- Institut de Recherche pour le Développement (FR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-11-13
- DOI
- https://doi.org/10.1371/journal.pone.0336239
- Primary Topic
- SARS-CoV-2 and COVID-19 Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00